Your browser doesn't support javascript.
loading
A comprehensive evaluation of humoral immune response to second and third SARS-CoV-2 mRNA vaccination in patients with malignant lymphoma.
Suzuki, Tomotaka; Kusumoto, Shigeru; Kamezaki, Yoshiko; Hashimoto, Hiroya; Nishitarumizu, Nozomi; Nakanishi, Yoko; Kato, Yukiyasu; Kawai, Akimi; Matsunaga, Naohiro; Ebina, Toru; Nakamura, Tomoyuki; Marumo, Yoshiaki; Oiwa, Kana; Kinoshita, Shiori; Narita, Tomoko; Ito, Asahi; Inagaki, Atsushi; Ri, Masaki; Komatsu, Hirokazu; Aritsu, Takashi; Iida, Shinsuke.
Afiliación
  • Suzuki T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan. skusumot@med.nagoya-cu.ac.jp.
  • Kamezaki Y; Scientific Information, Scientific Affairs, Sysmex Corporation, Kobe, Hyogo, Japan.
  • Hashimoto H; Clinical Research Management Center, Nagoya City University Hospital, Nagoya, Japan.
  • Nishitarumizu N; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Nakanishi Y; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Kato Y; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Kawai A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Matsunaga N; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Ebina T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Nakamura T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Marumo Y; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Oiwa K; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Kinoshita S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Narita T; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Ito A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Inagaki A; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Ri M; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Komatsu H; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
  • Aritsu T; Scientific Information, Scientific Affairs, Sysmex Corporation, Kobe, Hyogo, Japan.
  • Iida S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, 1, Kawasumi, Mizuho-Cho, Mizuho-Ku, Nagoya, Aichi, Japan.
Int J Hematol ; 117(6): 900-909, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36790667
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Linfoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Linfoma Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Int J Hematol Asunto de la revista: HEMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón